We used a central randomisation system to allocate participants to intravenous MgSO ( 4 ) ( 2 g in 20 min ) or nebulised MgSO ( 4 ) ( three 500 mg doses in 1 h ) alongside standard therapy including salbutamol , or placebo control plus standard therapy alone .